TRAX · ISSUER CIK 2091349
First Tracks Biotherapeutics, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 2 First Tracks Biotherapeutics, Inc. insiders reported $0.00 of open-market purchases and $1.8M of sales on SEC Form 4.
↗2 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 0 of 1 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$1.8MInsider selling
−$1.8MNet open-market
Sep 17, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 17, 202616:05 | Sep 15, 2026 | TRAX | Director | M · Exercise | — | +1,300 | 17,995 | +8% | — | ||
| Sep 4, 202616:25 | Sep 2, 2026 | TRAX | Director | S · Sell | $44.78 | −39,265 | 15,660 | -71% | −$1.8M | ||
| Sep 4, 202616:25 | Sep 2, 2026 | TRAX | Director | M · Exercise | $5.74 | +39,265 | 54,925 | +251% | $225K |